Please assess the completion status of the following clinical trial:

Trial Title: Study of orBec® With Prednisone Therapy in the Treatment of Patients With Graft Versus Host Disease (GVHD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Receipt of allogeneic hematopoietic cell transplant~* Diagnosis of GI graft vs. host disease (GVHD)~* No GI infection~* Must be able to swallow tablets~* Must be able to read and understand informed consent~* Adequate birth control methods for the duration of the study~Exclusion Criteria:~* Significant Skin GVHD~* Liver GVHD~* Persistent vomiting~* HIV positive~* Pregnancy/lactation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- orBec® (Type: EXPERIMENTAL): Investigational drug
- Placebo (Type: PLACEBO_COMPARATOR): Control

Based on this trial design, predict the completion outcome and termination type (if applicable).